Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - NASDAQ:CROX - US2270461096 - Common Stock

80.36 USD
-0.18 (-0.22%)
Last: 9/18/2025, 6:00:29 PM
80.35 USD
-0.01 (-0.01%)
After Hours: 9/18/2025, 6:00:29 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CROX. CROX was compared to 49 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making CROX a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on CROX. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
CROX had a positive operating cash flow in the past year.
In the past 5 years CROX has always been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

CROX's Return On Assets of 5.31% is fine compared to the rest of the industry. CROX outperforms 67.35% of its industry peers.
CROX has a better Return On Equity (16.64%) than 71.43% of its industry peers.
CROX has a better Return On Invested Capital (24.29%) than 93.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 12.08%.
The 3 year average ROIC (22.59%) for CROX is below the current ROIC(24.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROIC 24.29%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

CROX has a Profit Margin of 5.72%. This is in the better half of the industry: CROX outperforms 73.47% of its industry peers.
CROX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 24.24%, CROX belongs to the best of the industry, outperforming 97.96% of the companies in the same industry.
CROX's Operating Margin has improved in the last couple of years.
CROX has a Gross Margin of 59.36%. This is in the better half of the industry: CROX outperforms 79.59% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CROX has less shares outstanding
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.67. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CROX (3.67) is better than 69.39% of its industry peers.
The Debt to FCF ratio of CROX is 1.79, which is an excellent value as it means it would take CROX, only 1.79 years of fcf income to pay off all of its debts.
CROX has a better Debt to FCF ratio (1.79) than 85.71% of its industry peers.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
The Debt to Equity ratio of CROX (0.97) is worse than 71.43% of its industry peers.
Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Altman-Z 3.67
ROIC/WACC2.28
WACC10.66%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.54 indicates that CROX should not have too much problems paying its short term obligations.
CROX's Current ratio of 1.54 is on the low side compared to the rest of the industry. CROX is outperformed by 67.35% of its industry peers.
CROX has a Quick Ratio of 1.54. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
CROX has a Quick ratio (0.97) which is comparable to the rest of the industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.97
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CROX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.81%.
The Earnings Per Share has been growing by 51.64% on average over the past years. This is a very strong growth
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.04%.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%

3.2 Future

CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.84% yearly.
CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.29% yearly.
EPS Next Y-8.29%
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%
EPS Next 5Y2.84%
Revenue Next Year-2.41%
Revenue Next 2Y-0.79%
Revenue Next 3Y-0.08%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated cheaply with a Price/Earnings ratio of 6.02.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CROX to the average of the S&P500 Index (27.41), we can say CROX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.63, the valuation of CROX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CROX to the average of the S&P500 Index (22.88), we can say CROX is valued rather cheaply.
Industry RankSector Rank
PE 6.02
Fwd PE 6.63
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued cheaply inside the industry as 93.88% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaper than 93.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.71
EV/EBITDA 5.18
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
CROX's earnings are expected to decrease with -4.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (9/18/2025, 6:00:29 PM)

After market: 80.35 -0.01 (-0.01%)

80.36

-0.18 (-0.22%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-27 2025-10-27/amc
Inst Owners101.38%
Inst Owner Change-3.38%
Ins Owners2.52%
Ins Owner Change0.35%
Market Cap4.39B
Analysts75.45
Price Target93.11 (15.87%)
Short Float %12.16%
Short Ratio3.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.97%
Min EPS beat(2)3.5%
Max EPS beat(2)18.44%
EPS beat(4)4
Avg EPS beat(4)11.28%
Min EPS beat(4)3.5%
Max EPS beat(4)18.44%
EPS beat(8)8
Avg EPS beat(8)12.22%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)16
Avg EPS beat(16)15.25%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.22%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)6
Avg Revenue beat(12)0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.5%
PT rev (1m)-26.46%
PT rev (3m)-28.61%
EPS NQ rev (1m)-11.49%
EPS NQ rev (3m)-36.47%
EPS NY rev (1m)-6.26%
EPS NY rev (3m)-7.98%
Revenue NQ rev (1m)-2.15%
Revenue NQ rev (3m)-12.38%
Revenue NY rev (1m)-3.98%
Revenue NY rev (3m)-4.05%
Valuation
Industry RankSector Rank
PE 6.02
Fwd PE 6.63
P/S 1.06
P/FCF 5.71
P/OCF 5.24
P/B 3.09
P/tB N/A
EV/EBITDA 5.18
EPS(TTM)13.35
EY16.61%
EPS(NY)12.13
Fwd EY15.09%
FCF(TTM)14.08
FCFY17.52%
OCF(TTM)15.33
OCFY19.08%
SpS75.77
BVpS26.02
TBVpS-5.84
PEG (NY)N/A
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 5.31%
ROE 16.64%
ROCE 26.86%
ROIC 24.29%
ROICexc 25.67%
ROICexgc 50.56%
OM 24.24%
PM (TTM) 5.72%
GM 59.36%
FCFM 18.58%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexcg growth 3Y-0.46%
ROICexcg growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score8
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.79
Debt/EBITDA 1.28
Cap/Depr 92.37%
Cap/Sales 1.65%
Interest Coverage 11.92
Cash Conversion 77.72%
Profit Quality 325.08%
Current Ratio 1.54
Quick Ratio 0.97
Altman-Z 3.67
F-Score8
WACC10.66%
ROIC/WACC2.28
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.81%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%5.49%
EPS Next Y-8.29%
EPS Next 2Y-3.97%
EPS Next 3Y-4.15%
EPS Next 5Y2.84%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%3.41%
Revenue Next Year-2.41%
Revenue Next 2Y-0.79%
Revenue Next 3Y-0.08%
Revenue Next 5Y2.29%
EBIT growth 1Y-6.14%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-1.52%
EBIT Next 3Y-1.8%
EBIT Next 5Y3.43%
FCF growth 1Y3.44%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-1.37%
OCF growth 3Y20.5%
OCF growth 5Y61.62%